UPDATE : Friday, June 5, 2020
상단여백
iCure to apply for testing incrementally modified cancer drugs in US
iCure BNP said that it plans to apply for a phase 1 trial to change antican...
by Lee Han-soo  |  2019-11-13 17:35
라인
JW Pharmaceutical launches joint-stock company in Vietnam
JW Pharmaceutical said that it has formally launched Euvipharm Joint Stock ...
by Lee Han-soo  |  2019-11-13 16:52
라인
‘Generic drugs must indicate ingredient names on label’
“The results of ranitidine’s recall were sharply different from those of va...
by Kim Yun-mi  |  2019-11-13 15:51
라인
Daewoong releases trial results for autoimmune disease treatment in US
Daewoong Pharmaceutical has presented clinical trial results on DWP212525, ...
by Lee Han-soo  |  2019-11-12 14:09
라인
Hanmi to get ₩11.6 billion in royalty if FDA approves Rolontis
Spectrum, Hanmi’s U.S. partner, said Hanmi can secure 11.6 billion won ($9....
by Lee Han-soo  |  2019-11-11 18:02
라인
Genexine’s new immunotherapy shows stability even in high dose
GX-I7, a new immunotherapy candidate being developed jointly by Genexine an...
by Jeong Sae-im  |  2019-11-11 13:36
라인
Medpacto releases trial results at US conference
Medpacto, a subsidiary of Theregen ETEX, said Monday that it has presented ...
by Lee Han-soo  |  2019-11-11 13:27
라인
Yuhan, Cyclica to co-develop new drugs
Yuhan Corp. said that it would develop a new drug with Cyclica, a Canadian ...
by Lee Han-soo  |  2019-11-07 18:01
라인
Takeda’s labor turmoil goes to extremes amid rumored unit sell-off
Takeda Pharmaceutical Korea’s conflict between labor and management is risi...
by Kim Yun-mi  |  2019-11-07 16:10
라인
‘One-third of heart attack survivors overlook risk of recurrence’
Amgen Korea has released findings from a survey on Korean heart attack surv...
by Lee Han-soo  |  2019-11-06 16:34
라인
AbbVie’s hepatitis C drug gets 8-week therapy regardless of cirrhosis
AbbVie said it has obtained regulatory approval for an eight-week treatment...
by Kim Yun-mi  |  2019-11-06 16:00
라인
Crystal Genomics, Daehwa win patent for patch-form arthritis drug
Crystal Genomics and Daehwa Pharmaceutical said they have registered a pate...
by Lee Han-soo  |  2019-11-06 15:57
라인
Dong-A ST's treatment of nail athlete's foot dominates local market
Dong-A ST is strengthening its position in the toenail athlete's foot t...
by Lee Han-soo  |  2019-11-06 14:09
라인
Regulator to consider re-classifying choline alfoscerate as functional food
The Ministry of Food and Drug Safety has requested drugmakers to submit eff...
by Kim Yun-mi  |  2019-11-06 13:54
라인
Daewoong to sell Merck's cardiovascular disease treatment
Merck Biopharma Korea said that Daewoong would market Concor, its cardiovas...
by Lee Han-soo  |  2019-11-05 15:05
라인
Merck Korea hurries to close GM part despite union’s protest
Merck Biopharma Korea is stepping up the closure of general medicine (GM) d...
by Kim Yun-mi  |  2019-11-05 15:04
라인
[Interview with global pharmas] 'Pfizer Korea combines Pfizer's outstanding innovation with Koreans’ talents'
Pfizer Korea has recently celebrated its 50th anniversary. Over the past ha...
by Lee Han-soo  |  2019-11-05 12:46
라인
Yuhan, Dong-A, HanAll see Q3 earnings jump on licensing-out deals
Three local pharmaceutical companies enjoyed robust growth in operating inc...
by Jeong Sae-im  |  2019-11-04 15:52
라인
Takeda Korea fires union leader to worsen labor-management dispute
Takeda Pharmaceutical Korea dismissed Kim Young-buk, the leader of Korea De...
by Kim Yun-mi  |  2019-11-04 15:03
라인
Hanmi’s oral anticancer treatment becomes orphan drug in Europe
Hanmi Pharmaceutical said that Athenex, its U.S. partner, has won orphan dr...
by Lee Han-soo  |  2019-11-01 17:50
여백
여백
여백
Back to Top